1.
Ann Cardiol Angeiol (Paris)
; 72(4): 101610, 2023 Oct.
Article
in French
| MEDLINE
| ID: mdl-37300904
ABSTRACT
Peripartum cardiomyopathy is a life-threatening condition that requires urgent diagnosis and management. Bromocriptine was established as disease specific therapy; less data is known about Cabergolin which is another prolactin secretion inhibitor. In this paper we report 4 peripartum cardiomyopathy cases treated successfully with Cabergoline, including a cardiogenic shock case requiring mechanical circulatory support.